pantoprazole has been researched along with Kidney Failure in 2 studies
Pantoprazole: 2-pyridinylmethylsulfinylbenzimidazole proton pump inhibitor that is used in the treatment of GASTROESOPHAGEAL REFLUX and PEPTIC ULCER.
pantoprazole : A member of the class of benzimidazoles that is 1H-benzimidazole substituted by a difluoromethoxy group at position 5 and a [(3,4-dimethoxypyridin-2-yl)methyl]sulfinyl group at position 2.
Kidney Failure: A severe irreversible decline in the ability of kidneys to remove wastes, concentrate URINE, and maintain ELECTROLYTE BALANCE; BLOOD PRESSURE; and CALCIUM metabolism.
| Excerpt | Relevance | Reference |
|---|---|---|
| "We report a case of a potential drug-drug interaction in a woman treated by a first injection of high-dose methotrexate for a T-lymphoblastic lymphoma." | 1.37 | Suspicion of drug-drug interaction between high-dose methotrexate and proton pump inhibitors: a case report - should the practice be changed? ( Bouafia, F; Franchon, E; Gouraud, A; Pham, BN; Ranchon, F; Rioufol, C; Salles, G; Schwiertz, V; Vantard, N; Vial, T; You, B, 2011) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ranchon, F | 1 |
| Vantard, N | 1 |
| Gouraud, A | 1 |
| Schwiertz, V | 1 |
| Franchon, E | 1 |
| Pham, BN | 1 |
| Vial, T | 1 |
| You, B | 1 |
| Bouafia, F | 1 |
| Salles, G | 1 |
| Rioufol, C | 1 |
| Hałoń, A | 1 |
1 review available for pantoprazole and Kidney Failure
| Article | Year |
|---|---|
[Tubulointerstitial changes in glomerular kidney diseases].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Chronic Disease; Humans; Kidney Glomerulus; Kidney Tubular | 2011 |
1 other study available for pantoprazole and Kidney Failure
| Article | Year |
|---|---|
Suspicion of drug-drug interaction between high-dose methotrexate and proton pump inhibitors: a case report - should the practice be changed?
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Acyclovir; Antimetabolites, Antineoplastic; Antiviral Agent | 2011 |